You excel at cardio but struggle with strength. Your genes may be the reason.

Alpha-actinin-3 is a structural protein that lives inside fast-twitch muscle fibers, the ones responsible for explosive power, sprinting, and heavy lifting. It acts like a scaffold that holds the contractile machinery of the muscle in place, allowing fast-twitch fibers to generate maximum force quickly.

The ACTN3 R577X variant comes in three forms: RR (two copies of the working gene), RX (one working copy), or XX (no functional copies). Roughly 18% of people of European ancestry carry the XX genotype, which completely eliminates functional ACTN3 in fast-twitch fibers. When you have the XX variant, your fast-twitch fibers are structurally compromised, reducing your capacity for explosive power and heavy strength training. You don’t lose the fibers themselves, but they become less efficient at generating force.

This explains why heavy compound movements feel harder for you than steady-state cardio. Your nervous system can’t recruit fast-twitch fibers as effectively, so even when you’re trying to lift heavy, your body defaults to recruiting slow-twitch endurance fibers instead. You’ll never feel as explosive as an RR person doing the same lift, no matter how much you practice.

PGC-1 alpha is the master switch that tells your cells to build new mitochondria in response to exercise. When you do endurance training, this gene flips on and triggers a cascade that creates more cellular energy factories. More mitochondria means more aerobic capacity, better endurance, and faster cardio adaptations.

The PPARGC1A Gly482Ser variant affects this process. Roughly 35-40% of people carry the Ser variant, which reduces mitochondrial biogenesis in response to exercise training. When you have the Ser variant, your cells build new mitochondria more slowly, which means your aerobic capacity doesn’t improve as dramatically from cardio training as it does for Gly-carriers. But here’s the flip side: for strength training, which relies less on mitochondrial density and more on mechanical tension and muscle damage, this variant becomes less relevant. So while Gly-carriers see huge aerobic gains, Ser-carriers like you see more balanced adaptations across training types, or even better strength responses relative to cardio responses in some contexts.

But if you’re experiencing the opposite problem, a strength deficit relative to cardio, then a different mechanism is likely at play. This variant explains why your cardio improvements plateau while your strength struggles.

The beta-2 adrenergic receptor sits on the surface of your fat cells and listens for epinephrine (adrenaline) during exercise. When adrenaline binds to this receptor, it tells your fat cells to break down stored fat and release it into the bloodstream for fuel. This process is essential for fat loss during training, especially during moderate-intensity work and steady-state cardio.

The ADRB2 Gln27Glu and Arg16Gly variants impair this fat mobilization process. Roughly 40% of the population carries variants that reduce catecholamine-stimulated lipolysis, meaning your fat cells don’t respond as robustly to the adrenaline signal during exercise. Less fat is released into your bloodstream, so you’re burning proportionally more carbohydrate and less fat during the same workout. For cardio, you can overcome this with high volume and extended duration. For strength training with shorter, intense bursts, the problem is worse: you’re not mobilizing fat effectively during the brief metabolic window when you need it most.

This is why you might do the “right” strength workout and see minimal body composition change. Your nervous system is signaling fat mobilization correctly, but your fat cells aren’t listening effectively. The problem isn’t effort or adherence; it’s a receptor mismatch.

The vitamin D receptor is the lock that lets vitamin D do its job inside muscle cells. Vitamin D is required for muscle protein synthesis, calcium signaling, and the entire repair cascade after strength training. Without adequate vitamin D signaling, your muscles cannot recover efficiently from heavy lifting, no matter how much protein you eat.

The VDR BsmI and FokI variants affect how efficiently your cells respond to vitamin D. Roughly 30-50% of the population carries less optimal variants that impair the vitamin D signaling cascade, reducing muscle protein synthesis and calcium handling during recovery. This doesn’t mean you’re vitamin D deficient in the blood test sense; it means your muscles can’t use the vitamin D you have. The consequence is slower recovery, reduced strength gains from training, and higher injury risk during heavy lifting.

For cardio, this is less limiting because steady-state endurance work is gentler on the calcium-handling system. But for strength training, which creates micro-damage that requires rapid calcium signaling and protein synthesis, the VDR variant becomes a bottleneck. You could be eating enough protein and getting enough sleep, but if your VDR signaling is impaired, your muscles simply won’t adapt as quickly.

Superoxide dismutase 2 is an antioxidant enzyme that lives inside your mitochondria and neutralizes free radicals created during energy production. During intense exercise, your mitochondria produce a lot of reactive oxygen species (ROS). SOD2 is your cellular defense against this oxidative stress. Without sufficient SOD2 activity, ROS accumulates, damaging muscle proteins and delaying recovery.

The SOD2 Val16Ala variant affects enzyme efficiency. Roughly 40% of people homozygous for the variant have impaired oxidative stress clearance during exercise, leading to higher muscle damage, slower recovery, and greater delayed-onset muscle soreness (DOMS). Strength training generates more acute oxidative stress per unit of work than cardio does, which means the SOD2 variant hits you harder during heavy lifting. A single intense leg day can leave you sore for five days, while a cardio session produces minimal soreness.

This isn’t weakness; it’s biology. Your muscles are experiencing more oxidative damage per rep than someone with an efficient SOD2 variant. The consequence is that you need longer recovery windows between heavy sessions, which means lower training frequency for strength work, which means slower progress.

MTHFR converts folate from your diet into methylfolate, the active form your cells can use. This is critical for making red blood cells, maintaining vascular function, and managing homocysteine levels. Homocysteine is an amino acid that, in elevated amounts, damages the endothelium (the lining of blood vessels) and impairs oxygen delivery to muscles.

The MTHFR C677T variant is carried by roughly 40% of people of European ancestry. This variant reduces MTHFR enzyme efficiency by 40-70%, leading to elevated homocysteine and impaired vascular function during exercise. With high homocysteine, your blood vessels can’t dilate as effectively, oxygen delivery to working muscles decreases, and aerobic capacity suffers. You also can’t produce red blood cells as efficiently, worsening oxygen carrying capacity.

For you, this creates a paradox: you feel naturally drawn to cardio, but your vascular function is compromised, so even steady-state cardio doesn’t feel as rewarding as it should. During strength training, the problem compounds: your muscles don’t receive oxygen quickly enough for optimal recovery between sets, and your mitochondrial efficiency is further impaired by functional B12 and folate deficiency.